Colgate-Palmolive Co (CL) concluded trading on Wednesday at a closing price of $87.46, with 5.06 million shares of worth about $442.88 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -10.20% during that period and on January 08, 2025 the price saw a gain of about 0.08%. Currently the company’s common shares owned by public are about 817.01M shares, out of which, 816.09M shares are available for trading.
Stock saw a price change of -3.79% in past 5 days and over the past one month there was a price change of -7.18%. Year-to-date (YTD), CL shares are showing a performance of -3.79% which increased to 8.78% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $79.69 but also hit the highest price of $109.30 during that period. The average intraday trading volume for Colgate-Palmolive Co shares is 4.44 million. The stock is currently trading -4.47% below its 20-day simple moving average (SMA20), while that difference is down -5.95% for SMA50 and it goes to -9.10% lower than SMA200.
Colgate-Palmolive Co (NYSE: CL) currently have 817.01M outstanding shares and institutions hold larger chunk of about 84.45% of that.
The stock has a current market capitalization of $71.46B and its 3Y-monthly beta is at 0.44. PE ratio of stock for trailing 12 months is 25.13, while it has posted earnings per share of $3.48 in the same period. Its PEG reads 3.14 and has Quick Ratio of 0.68 while making debt-to-equity ratio of 19.39. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CL, volatility over the week remained 1.55% while standing at 1.49% over the month.
Stock’s fiscal year EPS is expected to rise by 10.77% while it is estimated to increase by 7.22% in next year. EPS is likely to grow at an annualized rate of 8.00% for next 5-years, compared to annual growth of 0.18% made by the stock over the past 5-years.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Stifel on October 28, 2024 offering a Hold rating for the stock and assigned a target price range of between $105 and $101 to it. Coverage by Piper Sandler stated Colgate-Palmolive Co (CL) stock as an Overweight in their note to investors on September 24, 2024, suggesting a price target of $121 for the stock. On September 16, 2024, Wells Fargo Downgrade their recommendations, while on September 09, 2024, Deutsche Bank Downgrade their ratings for the stock with a price target of $109. Stock get a Hold rating from HSBC Securities on July 26, 2024.
